Pharmacological characterization of extracellular acidification rate responses in human D(2(long)), D3 and D4.4 receptors expressed in Chinese hamster ovary cells

British Journal of Pharmacology

Volumn 127, Issue 5, 1999, Pages 1135-1144

  Coldwell, M C ^a   Boyfield, I ^a   Brown, A M ^a   Stemp, G ^a   Middlemiss, D N ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

CHO cells; D(2(long)); D3; D4.4; Human dopamine receptors; Microphysiometry

Indexed keywords

2 DIPROPYLAMINO 5 METHOXY 1 METHYLTETRALIN; AMILORIDE; CLOZAPINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR STIMULATING AGENT; DOPAMINE 4 RECEPTOR; DOPAMINE 4 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; PERTUSSIS TOXIN; PRECLAMOL; QUINPIROLE; RECEPTOR SUBTYPE; SULPIRIDE; UNCLASSIFIED DRUG;

ACIDIFICATION; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CHO CELL; CONTROLLED STUDY; DRUG POTENCY; ENANTIOMER; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING;

AMILORIDE; ANIMALS; BINDING, COMPETITIVE; CHO CELLS; CRICETINAE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; HUMANS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RECEPTORS, DOPAMINE D4;

EID: 0032773336     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702657     Document Type: Article

References (40)

1. 4 receptor variants. J. Neurochem., 65, 1157-1165.
2. 3 receptors-GppNHp shifts are explained by the presence of more than one binding site in each clone. Br. J. Pharmacol., 108, 277P.
3. BOWEN, W.P. & JERMAN, J.C. (1995). Nonlinear regression using spreadsheets. Trends Pharmacol. Sci., 16, 413-417.
4. 3 receptors, expressed in the same cell line, using the Cytosensor microphysiometer. Biochem. Soc. Trans., 24, 57S.
5. 3 dopamine receptors. Neuropsychopharmacology, 12, 335-345.
6. 3 dopamine receptors. Science, 250, 1814-1816.
7. 4 dopamine receptor-mediated signaling events determined in transfected Chinese hamster ovary cells. J. Biol. Chem., 269, 11813-11819.
8. 2 dopamine receptors. Mol. Pharmacol., 45, 51-60.
9. 2long dopamine receptors expressed in recombinant cells. Br. J. Pharmacol., 118, 1544-1550.
10. GIROS, B., MATRES, M.P., PILON, C., SOKOLOFF, P. & SCHWARTZ, J.C. (1991). Shorter variants of the D3 dopamine receptor produced through various patterns of alternative splicing. Biochem. Biophys. Res. Comm., 176, 1584-1592.
11. GRANDY, D.K., MARCHIONNI, M.A., MAKAM, H., STOFKO, R.E., ALFANO, M., FROTHINGHAM, L., FISCHER, J.B., BURKEHOWIE, K.J., BUNZOW, J.R., SERVER, A.C. & CIVELLI, O. (1989). Cloning of the cDNA and gene for a human D2-dopamine receptor. Proc. Natl. Acad. Sci. U.S.A., 88, 9175-9179.
12. 3 receptor: opposite and synergistic interactions with cyclic AMP. J. Neurochem., 68, 1-9.
13. 3 receptor ligand, (+)-UH232, is a partial agonist. Eur. J. Pharmacol., 282, R3-R4.
14. 3 receptor. Biochem. Soc. Trans., 24, 193-198.
15. 4 dopamine receptors determined in transfected cell lines. Clin. Neuropharmacol., 18, S25-S33.
16. 4 dopamine receptors in HEK293 cells. J. Recep. Signal Trans. Res., 15, 267-281.
17. MCCONNELL, H.M., OWICKI, J.C., PARCE, J.W., MILLER, D.L., BAXTER, G.T., WADA, H.G. & PITCHFORD, S. (1992). The Cytosensor microphysiometer: biological applications of silicon technology. Science, 257, 1096-1912.
18. 4 dopamine receptor in a stable cell line. FEBS Lett., 345, 147-150.
19. 3 receptors. Eur. J. Pharmacol., 249, R5-R6.
20. 4 receptor selective antagonist. J. Pharm. Exp. Ther., 279, 1392-1403.
21. + exchange of G-protein coupled receptors. Methods Neurosci., 25, 225-241.
22. + exchange assessed by quantification of extracellular acidification. J. Biol. Chem., 267, 25748-25753.
23. O'DOWD, B.F. (1993). Structures of dopamine-receptors. J. Neurochem., 60, 804-816.
24. OWICKI, J.C., PARCE, J.W., KERSCO, K.M., SIGAL, G.B., WADA, H.G., MIUR, V.C., BOUSSE, L.J., ROSS, K.L. & MCCONNELL, H.M. (1990). Continuous monitoring of receptor mediated changes in metabolic rates in living cells. Proc. Natl. Acad. Sci. U.S.A., 87, 4007-4011.
25. PARCE, J.W., OWICKI, J.C., HERSCO, K.M., SIGAL, G.B., WADA, H.G., MUIR, V.C., BOUSSE, L.J., ROSS, K.L. & MCCONNELL, H.M. (1989). Detection of cell-affecting agents with a silicon biosensor. Science, 246, 243-247.
26. 4 receptor. Mol. Pharmacol., 50, 1658-1664.
27. 3 receptor in a transfected NG108-15 neuroblastoma-glioma hybrid cell line. Eur. J. Pharmacol., 268, 129-139.
28. REYNOLDS, G.P. (1996). Dopamine receptors and schizophrenia. Biochem. Soc. Trans., 24, 202-205.
29. 2 receptors. Neuroreport, 6, 329-332.
30. 3 dopamine receptors in differentiated neuroblastoma x glioma NG108-15 cells. Br. J. Pharmacol., 111, 391-393.
31. SEABROOK, G.R., PATEL, S., HUTSON, P.H., RAGAN, C.I. & BRISTOW, L.J. (1996). Functional relevance of dopamine receptors. Trends Pharmacol. Sci., 16, 406-407.
32. SEEMAN, P. & VAN TOL, H.H.M. (1994). Dopamine-receptor pharmacology. Trends Pharmacol. Sci., 15, 264-270.
33. 2A subtype. DNA, 8, 683-689.
34. SIBLEY, D.R. & MONSMA, F.J. (1992). Molecular biology of dopamine receptors. Trends Pharmacol. Sci., 13, 61-69.
35. 2 receptor. Eur. J. Pharmacol., 225, 331-337.
36. 3) as a target for neuroleptics. Nature, 347, 146-151.
37. STRANGE, P.G. (1992). Brain Biochemistry and Brain Disorders. ed. Strange, P.G. New York: Oxford University Press. pp 226-257.
38. SVENSSON, K., JOHANSSON, A.M., MAGNUSSON, T. & CARLSSON, A. (1986). (+)-AJ 76 and (+)-UH 232: central stimulants acting as preferential dopamine receptor antagonists. Naunyn Schmiedebergs Arch. Pharmacol., 334, 234-245.
39. TILFORD, N.S., BOWEN, W.P. & BAXTER, G.S. (1995). Robofit: a versatile macro-driven template for curve fitting, analysis and presentation in Microsoft Excel. Br. J. Pharmacol., 115, 160P.
40. 3-receptor: a post-synaptic receptor inhibitory on rat locomoter activity. J. Neural. Transm., 94, 11-19.